Study paves way to more efficient non-addictive treatment for chronic pain

FHS
October 4, 2024
12:24 pm

Researchers at Karolinska Institutet in Sweden have developed a new comprehensive mapping of genetic activity for understanding the causes of chronic pain.

Risk of non-alcoholic fatty liver disease for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus

Researchers investigated the link between non-alcoholic fatty liver disease in individuals with type 2 diabetes mellitus (T2DM) and all-cause death and cardiovascular disease.

February 16, 2024

Simtra BioPharma to invest $250m in US facility

Share this article Each process suite will have dedicated formulation/compounding rooms. Credit: Gorodenkoff / Shutterstock.com. Injectable contract development and manufacturing organisation (CDMO) Simtra BioPharma Solutions

March 1, 2024

Exclusive: AstraZeneca’s outgoing R&D chief Mene Pangalos reflects on a 14-year R&D turnaround and the industry’s future

When AstraZeneca R&D executive Mene Pangalos joined the company in 2010, the UK drug giant was facing existential threats: shrinking sales, a meek pipeline and

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.